Select a section from the left sidebar
Roseoside
- Family: Plantae - Asteraceae
- Kingdom: Plantae
-
Class: Glycoside
- Subclass: Megastigmane Glycoside
Canonical Smiles | OC[C@H]1O[C@@H](O[C@@H](/C=C/[C@@]2(O)C(=CC(=O)CC2(C)C)C)C)[C@@H]([C@H]([C@@H]1O)O)O |
---|---|
InChI | InChI=1S/C19H30O8/c1-10-7-12(21)8-18(3,4)19(10,25)6-5-11(2)26-17-16(24)15(23)14(22)13(9-20)27-17/h5-7,11,13-17,20,22-25H,8-9H2,1-4H3/b6-5+/t11-,13-,14-,15+,16-,17-,19-/m1/s1 |
InChIKey | SWYRVCGNMNAFEK-MHXFFUGFSA-N |
Formula | C19H30O8 |
HBA | 8 |
HBD | 5 |
MW | 386.44 |
Rotatable Bonds | 5 |
TPSA | 136.68 |
LogP | -0.58 |
Number Rings | 2 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Fraction CSP3 | 0.74 |
Exact Mass | 386.19 |
Number of Lipinski Rule Violations | 0 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Ruellia tuberosa | Acanthaceae | Plantae | 441035 |
2 | Ruellia patula | Acanthaceae | Plantae | 441006 |
3 | Tribulus parvispinus | Zygophyllaceae | Plantae | 2603131 |
4 | Conyza aegyptiaca | Asteraceae | Plantae | 741633 |
5 | Crepis sancta | Asteraceae | Plantae | — |
Showing of synonyms
Roseoside
54835-70-0
Roseoside A
(6S,9R)-roseoside
BOE4GN3B64
UNII-BOE4GN3B64
(4S)-4-hydroxy-3,5,5-trimethyl-4-[(E,3R)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]cyclohex-2-en-1-one
Blumenyl A beta-D-glucopyranoside
Vomifoliol 9-o-beta-D-glucopyranoside
(6S,9R)-6-Hydroxy-3-oxo-alpha-ionol 9-o-beta-D-glucopyranoside
2-Cyclohexen-1-one, 4-((1E,3R)-3-(beta-D-glucopyranosyloxy)-1-buten-1-yl)-4-hydroxy-3,5,5-trimethyl-, (4S)-
6S,9R-ROSEOSIDE
MLS000563052
CHEMBL482383
GLXC-18025
HMS2267F19
AKOS032948782
DA-57520
FS-10003
SMR001215826
BLUMENYL A .BETA.-D-GLUCOPYRANOSIDE
E88736
VOMIFOLIOL 9-O-.BETA.-D-GLUCOPYRANOSIDE
(6S,9R)-6-HYDROXY-3-OXO-.ALPHA.-IONOL 9-O-.BETA.-D-GLUCOPYRANOSIDE
2-CYCLOHEXEN-1-ONE, 4-((1E,3R)-3-(.BETA.-D-GLUCOPYRANOSYLOXY)-1-BUTEN-1-YL)-4-HYDROXY-3,5,5-TRIMETHYL-, (4S)-
- Mahmouda AA, Al-Shihrya SS, et al. (2009). Biological activity of a phloroglucinol glucoside derivative from Conyza aegyptiaca. Zeitschrift fur Naturforschung C,2009,64,513-517. [View] [PubMed]
- Samy MN, Khalil HE, et al. (2013). Chemical constituents from the leaves of Ruellia tuberosa. Chemistry of Natural Compounds,2013,49(1),175-176. [View]
- Ebada S, El-Kashef D, et al. (2019). Cytotoxic eudesmane sesquiterpenes from Crepis sancta. Phytochemistry Letters, 2019, 33, 46-48. [View] [PubMed]
- Perrone A, Plaza A, et al. (2005). Cytotoxic furostanol saponins and a megastigmane glucoside from Tribulus parvispinus. Journal of Natural Products,2005,68(10),1549-1553. [View] [PubMed]
- Samy MN, Khalil HE, et al. (2011). Three new flavonoid glycosides, byzantionoside B 6’-O-Sulfate and xyloglucoside of (Z)-hex-3-en-1-ol from Ruellia patula. Chemical and Pharmaceutical Bulletin,2011,59(6),725-729. [View] [PubMed]
Pubchem:
9930064
Cas:
54835-70-0
Gnps:
CCMSLIB00000579260
Zinc:
ZINC000031154891
Nmrshiftdb2:
60028459
Chembl:
CHEMBL482383
CPRiL:
79655
SMILES: O=C1C=CC(CC1)C=CCOC2CCCCO2
Level: 1
Mol. Weight: 386.44 g/mol
SMILES: O=C1C=CCCC1
Level: 0
Mol. Weight: 386.44 g/mol
SMILES: C1CCOCC1
Level: 0
Mol. Weight: 386.44 g/mol
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -5.21
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -4.900
- Human Oral Bioavailability 50%
- Non-Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- -1.63
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 0.650
- Plasma Protein Binding
- 59.48
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Non-Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 1.920
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- -2.500
- Biodegradation
- Toxic
- Carcinogenesis
- Toxic
- Crustacean
- Safe
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- 0.980
- Liver Injury II
- Safe
- hERG Blockers
- Safe
- Daphnia Maga
- 4.050
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -6.750
- Rat (Acute)
- 2.570
- Rat (Chronic Oral)
- 2.990
- Fathead Minnow
- 3.930
- Respiratory Disease
- Safe
- Skin Sensitisation
- Toxic
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 452.870
- Hydration Free Energy
- -16.820
- Log(D) at pH=7.4
- 0.120
- Log(P)
- -1.03
- Log S
- -1.39
- Log(Vapor Pressure)
- -11.75
- Melting Point
- 141.75
- pKa Acid
- 6.48
- pKa Basic
- 5.78
Protein Name | UniProt ID | Entry Name | Species | #Pharmacophore Points | Probability (0.7 ≤ Tversky Score ≤ 1.0) |
---|---|---|---|---|---|
Aldo-keto reductase family 1 member C2 | P52895 | AK1C2_HUMAN | Homo sapiens | 3 | 0.8883 |
Aldo-keto reductase family 1 member C2 | P52895 | AK1C2_HUMAN | Homo sapiens | 3 | 0.8883 |
Probable NDP-rhamnosyltransferase | Q9ALM8 | Q9ALM8_SACSN | Saccharopolyspora spinosa | 3 | 0.8092 |
Probable NDP-rhamnosyltransferase | Q9ALM8 | Q9ALM8_SACSN | Saccharopolyspora spinosa | 3 | 0.8092 |
Lactoylglutathione lyase | Q9CPU0 | LGUL_MOUSE | Mus musculus | 2 | 0.7523 |
Lactoylglutathione lyase | Q9CPU0 | LGUL_MOUSE | Mus musculus | 2 | 0.7523 |
Gag-Pol polyprotein | P0C6F2 | POL_HV1LW | Human immunodeficiency virus type 1 group M subtype B | 3 | 0.7438 |
Gag-Pol polyprotein | P0C6F2 | POL_HV1LW | Human immunodeficiency virus type 1 group M subtype B | 3 | 0.7438 |
Sulfotransferase 2A1 | Q06520 | ST2A1_HUMAN | Homo sapiens | 3 | 0.7426 |
Sulfotransferase 2A1 | Q06520 | ST2A1_HUMAN | Homo sapiens | 3 | 0.7426 |
Soluble acetylcholine receptor | Q8WSF8 | Q8WSF8_APLCA | Aplysia californica | 3 | 0.7417 |
Soluble acetylcholine receptor | Q8WSF8 | Q8WSF8_APLCA | Aplysia californica | 3 | 0.7417 |
FKBP-type peptidyl-prolyl cis-trans isomerase FkpA | P45523 | FKBA_ECOLI | Escherichia coli | 4 | 0.7320 |
FKBP-type peptidyl-prolyl cis-trans isomerase FkpA | P45523 | FKBA_ECOLI | Escherichia coli | 4 | 0.7320 |
beta-glucosidase | Q92AS9 | Q92AS9_LISIN | Listeria innocua serovar 6a | 3 | 0.7227 |
beta-glucosidase | Q92AS9 | Q92AS9_LISIN | Listeria innocua serovar 6a | 3 | 0.7227 |
Corticosteroid-binding globulin | P08185 | CBG_HUMAN | Homo sapiens | 3 | 0.7168 |
Corticosteroid-binding globulin | P08185 | CBG_HUMAN | Homo sapiens | 3 | 0.7168 |
Putative b-glycan phosphorylase | Q21MB1 | Q21MB1_SACD2 | Saccharophagus degradans | 4 | 0.7154 |
Putative b-glycan phosphorylase | Q21MB1 | Q21MB1_SACD2 | Saccharophagus degradans | 4 | 0.7154 |
CmeR | Q7B8P6 | Q7B8P6_CAMJU | Campylobacter jejuni | 2 | 0.7086 |
CmeR | Q7B8P6 | Q7B8P6_CAMJU | Campylobacter jejuni | 2 | 0.7086 |